These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1990958)

  • 1. Complement activation is a secondary rather than a causative factor in rabbit pulmonary artery ischemia/reperfusion injury.
    Bishop MJ; Giclas PC; Guidotti SM; Su ML; Chi EY
    Am Rev Respir Dis; 1991 Feb; 143(2):386-90. PubMed ID: 1990958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment with Cobra venom factor alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats.
    Mao YF; Yu QH; Zheng XF; Liu K; Liang WQ; Wang YW; Deng XM; Jiang L
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2207-17. PubMed ID: 23893188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung.
    Larsen GL; Webster RO; Worthen GS; Gumbay RS; Henson PM
    J Clin Invest; 1985 Mar; 75(3):902-10. PubMed ID: 3980730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cobra Venom Factor-induced complement depletion protects against lung ischemia reperfusion injury through alleviating blood-air barrier damage.
    Haihua C; Wei W; Kun H; Yuanli L; Fei L
    Sci Rep; 2018 Jul; 8(1):10346. PubMed ID: 29985461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases.
    Vogel CW; Fritzinger DC; Gorsuch WB; Stahl GL
    Thromb Haemost; 2015 Mar; 113(3):548-52. PubMed ID: 25031089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
    Kang HJ; Lee G; Kim JY; Lee SH; Wi HC; Hwang PG; Chung DH; Kim YT
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):149-56. PubMed ID: 15982598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.
    Till GO; Morganroth ML; Kunkel R; Ward PA
    Am J Pathol; 1987 Oct; 129(1):44-53. PubMed ID: 3661679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.
    Cheung AK; Parker CJ; Wilcox L
    Clin Exp Immunol; 1989 Nov; 78(2):299-306. PubMed ID: 12412765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte sequestration in pulmonary microvessels and lung injury following systemic complement activation in rabbits.
    Kuhnle GE; Kiefmann R; Sckell A; Kuebler WM; Groh J; Goetz AE
    J Vasc Res; 1999; 36(4):289-98. PubMed ID: 10474042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement and neutrophil-mediated injury of perfused rat lungs.
    Morganroth ML; Till GO; Kunkel RG; Ward PA
    Lab Invest; 1986 May; 54(5):507-14. PubMed ID: 3702342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass.
    Kuratani T; Matsuda H; Sawa Y; Kaneko M; Nakano S; Kawashima Y
    J Thorac Cardiovasc Surg; 1992 Mar; 103(3):564-8. PubMed ID: 1545556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of inflammatory lung injury in rabbits challenged intravascularly with complement-derived chemotactic factors.
    Webster RO; Larsen GL; Mitchell BC; Goins AJ; Henson PM
    Am Rev Respir Dis; 1982 Mar; 125(3):335-40. PubMed ID: 7065543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia.
    Jaeschke H; Farhood A; Bautista AP; Spolarics Z; Spitzer JJ
    Am J Physiol; 1993 Apr; 264(4 Pt 1):G801-9. PubMed ID: 8476062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming of phagocytes for reactive oxygen production during hepatic ischemia-reperfusion potentiates the susceptibility for endotoxin-induced liver injury.
    Liu P; Vonderfecht SL; Fisher MA; McGuire GM; Jaeschke H
    Circ Shock; 1994 May; 43(1):9-17. PubMed ID: 7982273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke.
    Lew SM; Gross CE; Bednar MM; Russell SJ; Fuller SP; Ellenberger CL; Howard D
    Brain Res Bull; 1999 Feb; 48(3):325-31. PubMed ID: 10229342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of post-ischemic lung reperfusion injury by fibrinolytic activity suppression.
    Edagawa M; Yoshida E; Matsuzaki Y; Shibuya K; Shibata K; Onitsuka T; Maruyama M
    Transplantation; 1999 Apr; 67(7):944-9. PubMed ID: 10221476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antigen-induced bronchoconstriction after intravascular complement activation with cobra venom factor. Reversal by granulocyte depletion.
    Regal JF; Fraser DG; Anderson DE; Solem LE
    J Immunol; 1993 Apr; 150(8 Pt 1):3496-505. PubMed ID: 8468484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperoxygenated solution preconditioning attenuates lung injury induced by intestinal ischemia reperfusion in rabbits.
    Gao C; Sun X; Zhang G; Zhang H; Zhao H; Yang Y; Han L; Xu L; Chai W
    J Surg Res; 2008 May; 146(1):24-31. PubMed ID: 18028953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease models.
    Vogel CW; Finnegan PW; Fritzinger DC
    Mol Immunol; 2014 Oct; 61(2):191-203. PubMed ID: 25062833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral perfusion abnormalities following complement activation. Clues to the mediators of organ ischemia in trauma and sepsis. First place winner: Conrad Jobst Award.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    Am Surg; 1988 Dec; 54(12):687-92. PubMed ID: 3195844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.